8-K/A filed September 11, 2026, 7:42 PM ET ticker BLGO CIK 0000880242

earnings confidence low sentiment neutral materiality 0.50

BioLargo Q2 2026 earnings town hall held; figures not visible in filing excerpt

BIOLARGO, INC.

BioLargo held Q2 2026 earnings call Sept 10, 2026 with CEO Dennis Calvert and CFO Charles Dargan.
No revenue, EPS, or guidance figures appear in the provided transcript excerpt; it cuts off at safe harbor language.
Investor relations contact Matt Kreps of Darrow Associates introduced the shareholder town hall.
Company addressed pre-submitted shareholder questions during the call; financial detail unavailable from this excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.